Tag:
iBio
Latest Headlines
Latest Headlines
iBio shares jump with flu shot clinical trial
iBio's shares have jumped 21% with the announcement that it has completed the first Phase I clinical trial of its plant-based vaccine for H1N1 influenza.
Fiocruz granted royalty-bearing license from iBio
IBio, which focuses on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases, has granted a commercial, royalty-bearing
Plant-based H1N1 vax starts clinical trial
The Fraunhofer Center for Molecular Biotechnology and iBio have found a new possibility for H1N1 vaccines. Rather than using traditional vaccine ingredients, the Newark, NJ-based center uses
FDA OKs studies with iBio/Fraunhofer plant-based vax
Plant-based product developer iBio, which announced just before Labor Day a deal with GE Healthcare and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine
International troika drives biomanufacturing platforms
GE Healthcare has teamed with Sweden's iBio and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine manufacturing gear. The arrangement capitalizes on GE's global life
iBio tech to be used for anthrax, plague vax
iBio has confirmed that its proprietary technology, the iBioLaunch platform, will help support a $5.3 million government-funded project for the development of a single vaccine to protect against both
